Literature DB >> 12061841

Oncostatin M production by human dendritic cells in response to bacterial products.

Takafumi Suda1, Kingo Chida, Akihito Todate, Kyotaro Ide, Kazuhiro Asada, Yutaro Nakamura, Kenichiro Suzuki, Hirofumi Kuwata, Hirotoshi Nakamura.   

Abstract

Oncostatin M (OSM) is a pleiomorphic cytokine that belongs to the IL-6 cytokine family. It is produced by activated T cells and monocytes/macrophages and plays an important role in the process of inflammatory responses. Although dendritic cells (DCs) have been shown to secrete a variety of cytokines, it is not elucidated whether DCs are able to produce OSM. To clarify this, using human DCs derived from peripheral blood cells, we measured the protein levels of OSM in the supernatants of DC cultures by ELISA and examined the expression of OSM mRNA by RT-PCR after stimulation with lipopolysaccharide (LPS) or fixed Staphylococcus aureus (SACS). Upon stimulation with bacterial products, DCs secreted a large amount of OSM protein in a dose- and time-dependent manner. Concomitantly, the expression of OSM mRNA by DCs was markedly up-regulated. Compared the ability of DCs to produce OSM with that of monocytes, which are major producers of OSM, DCs released significantly higher amounts of OSM protein in the culture supernatants than monocytes. These findings indicate for the first time that human monocyte-derived DCs can synthesize and secrete large amounts of OSM in response to bacterial products, suggesting that OSM produced by DCs at infectious sites may play a role in modulating inflammatory responses. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061841     DOI: 10.1006/cyto.2002.1023

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.

Authors:  Kathryn L Pothoven; James E Norton; Kathryn E Hulse; Lydia A Suh; Roderick G Carter; Erin Rocci; Kathleen E Harris; Stephanie Shintani-Smith; David B Conley; Rakesh K Chandra; Mark C Liu; Atsushi Kato; Nirmala Gonsalves; Leslie C Grammer; Anju T Peters; Robert C Kern; Paul J Bryce; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2015-04-01       Impact factor: 10.793

2.  Role of oncostatin M in the pathogenesis of vernal keratoconjunctivitis: focus on tissue remodeling.

Authors:  Keitaro Mashimo; Ayumi Usui-Ouchi; Yousuke Ito; Rei Wakasa-Arai; Norihiko Yokoi; Satoshi Kawasaki; Akira Murakami; Akira Matsuda; Nobuyuki Ebihara
Journal:  Jpn J Ophthalmol       Date:  2021-01-06       Impact factor: 2.447

3.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

4.  Human Cytokinome Analysis for Interferon Response.

Authors:  Suhad Al-Yahya; Linah Mahmoud; Fahad Al-Zoghaibi; Abdullah Al-Tuhami; Haithem Amer; Fahad N Almajhdi; Stephen J Polyak; Khalid S A Khabar
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

5.  A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans.

Authors:  Craig S Charron; Harry D Dawson; George P Albaugh; Patrick M Solverson; Bryan T Vinyard; Gloria I Solano-Aguilar; Aleksey Molokin; Janet A Novotny
Journal:  J Nutr       Date:  2015-09-30       Impact factor: 4.798

6.  Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.

Authors:  Frédéric Torossian; Bernadette Guerton; Adrienne Anginot; Kylie A Alexander; Christophe Desterke; Sabrina Soave; Hsu-Wen Tseng; Nassim Arouche; Laetitia Boutin; Irina Kulina; Marjorie Salga; Beulah Jose; Allison R Pettit; Denis Clay; Nathalie Rochet; Erica Vlachos; Guillaume Genet; Charlotte Debaud; Philippe Denormandie; François Genet; Natalie A Sims; Sébastien Banzet; Jean-Pierre Levesque; Jean-Jacques Lataillade; Marie-Caroline Le Bousse-Kerdilès
Journal:  JCI Insight       Date:  2017-11-02

7.  Induction of STAT3-Dependent CXCL5 Expression and Neutrophil Recruitment by Oncostatin-M during Pneumonia.

Authors:  Katrina E Traber; Kristie L Hilliard; Eri Allen; Gregory A Wasserman; Kazuko Yamamoto; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Am J Respir Cell Mol Biol       Date:  2015-10       Impact factor: 6.914

8.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

9.  Oncostatin M regulates secretoglobin 3A1 and 3A2 expression in a bidirectional manner.

Authors:  Takeshi Tomita; Atsushi Yamada; Masaaki Miyakoshi; Taketomo Kido; Faruk Sheikh; Achara Srisodsai; Atsushi Miyajima; Raymond P Donnelly; Shioko Kimura
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

10.  Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.

Authors:  Junya Kanda; Tatsuki Uchiyama; Naohisa Tomosugi; Masato Higuchi; Takashi Uchiyama; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2009-11-14       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.